Cipla Shares Gain Attention as CDSCO Approves Launch of Inhalation Insulin – A Game Changer?
Cipla, a pharmaceutical company, announced on Wednesday that the Central Drugs Standard Control Organization has given it permission to market and distribute Afrezza inhalation powder in India. The firm claims that Afrezza, a medicine developed and produced by MannKind Corporation (MannKind) USA, helps adult patients with diabetes mellitus achieve better glycemic control. Cipla will make … Read more
